医学
危险系数
内科学
肿瘤科
荟萃分析
微小残留病
髓系白血病
造血干细胞移植
置信区间
移植
梅德林
白血病
比例危险模型
政治学
法学
作者
Nicholas J. Short,Shouhao Zhou,Chenqi Fu,Donald A. Berry,Roland B. Walter,Sylvie D. Freeman,Christopher S. Hourigan,Xuelin Huang,Graciela Nogueras González,Hyunsoo Hwang,Xinyue Qi,Hagop M. Kantarjian,Farhad Ravandi
出处
期刊：JAMA Oncology
[American Medical Association]
日期：2020-10-08
卷期号：6 (12): 1890-1890
被引量：280
标识
DOI：10.1001/jamaoncol.2020.4600
摘要
Measurable residual disease (MRD) refers to neoplastic cells that cannot be detected by standard cytomorphologic analysis. In patients with acute myeloid leukemia (AML), determining the association of MRD with survival may improve prognostication and inform selection of efficient clinical trial end points.
科研通智能强力驱动
Strongly Powered by AbleSci AI
MchemG
YifanWang
pluto
VDC
ceeray23
剑指东方是为谁
斯寜
Xiaoxiao
迷人秋烟
Magali
cctv18
123
morena
小李老博
核桃
昏睡的蟠桃
Marciu33
nenoaowu
HEIKU
Ava
皖公网安备34019202002308
